Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Oct 7, 2010
Dr Heatehr Payne speaks about the importance of hormone therapy in the treatment of prostate cancer and the potential of new treatments such as LHRH agonists and the GnRH antagonist Degarelix. Dr Payne discusses bisphosphonates and considers the recent reports that the long term use may increase the chance of developing oesophageal cancer.
Dr Heather Payne of University College London in the UK speaking to ecancer.tv at ESTRO 2010